Insider Trading History of Smethurst Dominic

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Smethurst Dominic since 2021. This trader's CIK number is 1820549. At the time of last reporting, Smethurst Dominic was the Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc.. (stock ticker symbol CRBP). Also see all insider trading activities at Corbus Pharmaceuticals Holdings, Inc..

Note that in the past Smethurst Dominic also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Bicycle Therapeutics Plc (BCYC) by Smethurst Dominic

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 BCYC 0 $0 1,801 $52,337 0 $0
2021 BCYC 0 $0 0 $0 6,000 $111,300

Yearly summary of insider trading at Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Smethurst Dominic

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CRBP 0 $0 6,393 $43,331 0 $0


Insider trading activities at 2 companies by Smethurst Dominic:

1. Bicycle Therapeutics Plc (BCYC)

2. Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Table 1. Insider trading of Bicycle Therapeutics Plc (BCYC) by Smethurst Dominic

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-03 BCYC Sale 1,801 29.06 52,337
2021-09-23 BCYC Option Ex 6,000 18.55 111,300

Table 2. Insider trading of Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Smethurst Dominic

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-06 CRBP Sale 6,393 6.78 43,331

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smethurst Dominic (Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.